| T. Rowe Price Capital Appreciation | PRWCX | 38.66 | +0.13% | 35.63B | 22/11 | |
| T. Rowe Price Blue Chip Growth | TRBCX | 200.50 | -0.12% | 32.43B | 22/11 | |
| T. Rowe Price Capital Appreciation I | TRAIX | 38.70 | +0.16% | 29.42B | 22/11 | |
| T. Rowe Price Blue Chip Growth I | TBCIX | 201.81 | -0.12% | 29.76B | 22/11 | |
| T. Rowe Price Instl Large Cap Growth | TRLGX | 86.12 | -0.20% | 22.62B | 22/11 | |
| T. Rowe Price Growth Stock I | PRUFX | 111.54 | 0.00% | 15.82B | 22/11 | |
| T. Rowe Price Dividend Growth | PRDGX | 83.26 | +0.68% | 13.17B | 22/11 | |
| T. Rowe Price Mid-Cap Growth I | RPTIX | 113.98 | +0.96% | 13.55B | 22/11 | |
| T. Rowe Price Growth Stock | PRGFX | 111.08 | 0.00% | 12.69B | 22/11 | |
| T. Rowe Price Mid-Cap Growth | RPMGX | 113.61 | +0.95% | 12.6B | 22/11 | |
| T. Rowe Price Dividend Growth I | PDGIX | 83.23 | +0.68% | 11.54B | 22/11 | |
| T. Rowe Price Equity Index 500 I | PRUIX | 157.30 | +0.35% | 10.88B | 22/11 | |
| T. Rowe Price New Horizons I | PRJIX | 63.72 | +1.79% | 10.92B | 22/11 | |
| T. Rowe Price Health Sciences | PRHSX | 94.43 | +0.40% | 8.5B | 22/11 | |
| T. Rowe Price Equity Income | PRFDX | 39.36 | +0.67% | 8.6B | 22/11 | |
| T. Rowe Price Equity Income I | REIPX | 39.32 | +0.67% | 8.71B | 22/11 | |
| T. Rowe Price New Horizons | PRNHX | 63.28 | +1.80% | 8.75B | 22/11 | |
| T. Rowe Price New America Growth | PRWAX | 81.76 | +0.41% | 8.5B | 22/11 | |
| T. Rowe Price Equity Index 500 | PREIX | 157.27 | +0.35% | 8.34B | 22/11 | |
| T. Rowe Price Capital Opportunity | PRCOX | 59.40 | +0.27% | 6.92B | 22/11 | |